{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:43:46Z","timestamp":1786653826773,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Leishmania major<\/jats:italic>\n                      , the primary causative agent of cutaneous leishmaniasis, presents significant challenges for vaccine development due to antigenic diversity and the limitations of current therapeutic approaches. Therefore, this study aimed to use immunoinformatics computational approaches to identify novel vaccine candidates against leishmaniasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      We implemented a comprehensive multi-stage computational filtering strategy to systematically evaluate the complete\n                      <jats:italic toggle=\"yes\">L. major<\/jats:italic>\n                      proteome (8,038 proteins) for membrane-associated vaccine candidates. Using integrated antigenicity prediction VaxiJen v2.0, subcellular localization analysis combining UniProt annotations and DeepLoc 2.0 predictions, dual allergenicity assessment using AllerTOP v2.0 and AllergenFP v1.0, and extensive conservation analysis were conducted across five\n                      <jats:italic toggle=\"yes\">Leishmania<\/jats:italic>\n                      species (\n                      <jats:italic toggle=\"yes\">L. donovani, L. infantum<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">L. braziliensi<\/jats:italic>\n                      s,\n                      <jats:italic toggle=\"yes\">L. guyanensis<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">L. mexicana<\/jats:italic>\n                      ) with human homology screening.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The screening achieved a 321-fold enrichment, identifying 25 nonallergenic membrane-associated proteins with high antigenic potential and optimal safety profiles. These candidates have not been previously investigated as vaccine targets, representing an expansion of the existing therapeutic repertoire. Conservation analysis revealed distinct strategic categories: seven proteins demonstrated &gt;90% identity across multiple\n                      <jats:italic toggle=\"yes\">Leishmania<\/jats:italic>\n                      species, suggesting broad-spectrum vaccine potential, while eight showed moderate conservation (&gt;80%), indicating region-specific utility. Functional characterization revealed diverse membrane proteins, including novel adhesion molecules, transport proteins, and uncharacterized surface antigens. Critical safety assessment confirmed minimal human protein similarity (&lt;35% identity), significantly reducing autoimmunity risks.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      The bioinformatics data support the substantial untapped potential within parasitic proteomes and validate systematic computational screening as a potential strategy for vaccine development. The conservation patterns identified provide clear strategic guidance for developing either pan-\n                      <jats:italic toggle=\"yes\">Leishmania<\/jats:italic>\n                      vaccines for broad-spectrum protection or species-specific formulations for targeted regional use. However, additional\n                      <jats:italic toggle=\"yes\">in silico<\/jats:italic>\n                      and wet lab synthesis of the vaccine has to be conducted to confirm the potential of the protein candidates.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tp.tp_51_25","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:01:03Z","timestamp":1778007663000},"page":"29-39","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A multi-stage in silico filtering approach for Leishmania major proteome for the identification of novel vaccine candidates"],"prefix":"10.4103","volume":"16","author":[{"given":"Ali","family":"Abdulqader","sequence":"first","affiliation":[{"name":"Department of Bioinformatics, College of BioMedical Informatics, University of Information Technology and Communications, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinah Mohsin","family":"Arkah","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, College of BioMedical Informatics, University of Information Technology and Communications, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Sana\u2019a University, Sana\u2019a, Yemen"},{"name":"Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, University of Science and Technology, Sana\u2019a, Yemen"},{"name":"Nan Yang Academy of Sciences, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Shahir","family":"Shamsir","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Faculty of Science, University Teknologi Malaysia, Johor Bahru, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"R2-20260506","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/2229-5070.162487","article-title":"Visceral leishmaniasis","volume":"5","author":"Sunder","year":"2015","journal-title":"Trop Parasitol"},{"key":"R3-20260506","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"R4-20260506","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13071-024-06381-8","article-title":"Cutaneous leishmaniasis in sub-Saharan Africa: A systematic review of Leishmania species, vectors and reservoirs","volume":"17","author":"Blaizot","year":"2024","journal-title":"Parasit Vectors"},{"key":"R5-20260506","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1007\/s00436-021-07166-z","article-title":"Molecular characterization of Leishmania species from stray dogs and human patients in Saudi Arabia","volume":"120","author":"Alanazi","year":"2021","journal-title":"Parasitol Res"},{"key":"R6-20260506","first-page":"12","article-title":"Cutaneous leishmaniasis in Iraq and evaluation of its immune responses","volume":"5","author":"Jaafar","year":"2024","journal-title":"Int J Eng Artif Intell"},{"key":"R7-20260506","first-page":"2024","article-title":"Epidemiological aspects of Zoonotic Cutaneous Leishmaniasis (ZCL) in Iran, the Middle East, and Worldwide: A comprehensive systematic review","author":"Jamali","year":"2024","journal-title":"medRxiv"},{"key":"R8-20260506","doi-asserted-by":"crossref","first-page":"101664","DOI":"10.1016\/j.jddst.2020.101664","article-title":"A review of current treatments strategies based on paromomycin for leishmaniasis","volume":"57","author":"Matos","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"R9-20260506","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4103\/1995-7645.345944","article-title":"New developments in the treatment of cutaneous leishmaniasis","volume":"15","author":"Dinc","year":"2022","journal-title":"Asian Pac J Trop Med"},{"key":"R10-20260506","doi-asserted-by":"crossref","first-page":"508","DOI":"10.37349\/eds.2024.00059","article-title":"A review of leishmaniasis: current knowledge and future directions of heterocyclic molecules","volume":"2","author":"Masne","year":"2024","journal-title":"Explor Drug Sci"},{"key":"R11-20260506","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/2229-5070.129142","article-title":"Drug resistance in leishmaniasis: Newer developments","volume":"4","author":"Mohapatra","year":"2014","journal-title":"Trop Parasitol"},{"key":"R12-20260506","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","article-title":"Cutaneous leishmaniasis: A 2022 updated narrative review into diagnosis and management developments","volume":"23","author":"de Vries","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"R13-20260506","first-page":"21","article-title":"Recent advances in vaccines against Leishmania based on patent applications","volume":"12","author":"Thomaz-Soccol","year":"2018","journal-title":"Recent Pat Biotechnol"},{"key":"R14-20260506","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3389\/fimmu.2018.01043","article-title":"Peptide vaccines for leishmaniasis","volume":"9","author":"De Brito","year":"2018","journal-title":"Front Immunol"},{"key":"R15-20260506","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/vaccines9101058","article-title":"A T-cell epitope-based multi-epitope vaccine designed using human HLA specific T cell epitopes induces a near-sterile immunity against experimental visceral leishmaniasis in hamsters","volume":"9","author":"Arya","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R16-20260506","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13071-020-04064-8","article-title":"An immunoinformatic approach driven by experimental proteomics: In silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani Amastigotes","volume":"13","author":"Khan","year":"2020","journal-title":"Parasit Vectors"},{"key":"R17-20260506","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1038\/s41598-023-34863-9","article-title":"A state-of-the-art methodology for high-throughput in silico vaccine discovery against protozoan parasites and exemplified with discovered candidates for Toxoplasma gondii","volume":"13","author":"Goodswen","year":"2023","journal-title":"Sci Rep"},{"key":"R18-20260506","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.3389\/fimmu.2018.02213","article-title":"Immuno-informatics analysis to identify novel vaccine candidates and design of a multi-epitope based vaccine candidate against Theileria parasites","volume":"9","author":"Kar","year":"2018","journal-title":"Front Immunol"},{"key":"R19-20260506","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1074\/mcp.M116.058800","article-title":"Proteomics-driven antigen discovery for development of vaccines against Gonorrhea","volume":"15","author":"Zielke","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"R20-20260506","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1016\/j.vaccine.2016.03.079","article-title":"Advancing a vaccine to prevent human schistosomiasis","volume":"34","author":"Merrifield","year":"2016","journal-title":"Vaccine"},{"key":"R21-20260506","doi-asserted-by":"crossref","first-page":"105423","DOI":"10.1016\/j.ejps.2020.105423","article-title":"Exploring membrane proteins of Leishmania major to design a new multi-epitope vaccine using immunoinformatics approach","volume":"152","author":"Rabienia","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"R22-20260506","doi-asserted-by":"crossref","first-page":"18119","DOI":"10.1038\/s41598-022-22646-7","article-title":"Bioinformatics analysis for the purpose of designing a novel multi-epitope DNA vaccine against Leishmania major","volume":"12","author":"Rashidi","year":"2022","journal-title":"Sci Rep"},{"key":"R23-20260506","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1875035400801010022","article-title":"Bioinformatic approach for identifying parasite and fungal candidate subunit vaccines","volume":"1","author":"Doytchinova","year":"2008","journal-title":"Open Vaccine J"},{"key":"R24-20260506","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1093\/bioinformatics\/btx431","article-title":"DeepLoc: Prediction of protein subcellular localization using deep learning","volume":"33","author":"Almagro Armenteros","year":"2017","journal-title":"Bioinformatics"},{"key":"R25-20260506","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v. 2\u2013A server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J Mol Model"},{"key":"R26-20260506","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","article-title":"AllergenFP: Allergenicity prediction by descriptor fingerprints","volume":"30","author":"Dimitrov","year":"2014","journal-title":"Bioinformatics"},{"key":"R28-20260506","doi-asserted-by":"crossref","first-page":"107964","DOI":"10.1016\/j.exppara.2020.107964","article-title":"Assessing the composition of the plasma membrane of Leishmania (Leishmania) infantum and L. (L.) amazonensis using label-free proteomics","volume":"218","author":"Oliveira","year":"2020","journal-title":"Exp Parasitol"},{"key":"R29-20260506","doi-asserted-by":"crossref","first-page":"832106","DOI":"10.3389\/fimmu.2022.832106","article-title":"Conservation and evolution of antigenic determinants of SARS-CoV-2: An insight for immune escape and vaccine design","volume":"13","author":"Jaiswal","year":"2022","journal-title":"Front Immunol"},{"key":"R30-20260506","doi-asserted-by":"crossref","first-page":"100355","DOI":"10.1016\/j.jgeb.2024.100355","article-title":"multi-epitope vaccine design against leishmaniasis using IFN-\u03b3 inducing epitopes from immunodominant gp46 and gp63 proteins","volume":"22","author":"Dehghani","year":"2024","journal-title":"J Genet Eng Biotechnol"},{"key":"R31-20260506","doi-asserted-by":"crossref","first-page":"100626","DOI":"10.1016\/j.imu.2021.100626","article-title":"Leishmanolysin gp63: Bioinformatics evidences of immunogenic epitopes in Leishmania major for enhanced vaccine design against zoonotic cutaneous leishmaniasis","volume":"24","author":"Shams","year":"2021","journal-title":"Inform Med Unlocked"},{"key":"R32-20260506","doi-asserted-by":"crossref","first-page":"104189","DOI":"10.1016\/j.meegid.2020.104189","article-title":"Bioinformatics analyses of immunogenic T-cell epitopes of LeIF and PpSP15 proteins from Leishmania major and sand fly saliva used as model antigens for the design of a multi-epitope vaccine to control leishmaniasis","volume":"80","author":"Bordbar","year":"2020","journal-title":"Infect Genet Evol"}],"container-title":["Tropical Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tp.tp_51_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:42:52Z","timestamp":1786650172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tp.tp_51_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/tp.tp_51_25","relation":{},"ISSN":["2229-5070","2229-7758"],"issn-type":[{"value":"2229-5070","type":"print"},{"value":"2229-7758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-07-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}